Highbridge Capital Management’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Highbridge Capital Management’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-91,286	Closed	-$475K	–	2142
2015 Q4	$475K	Buy	+91,286	New	+$530K	0.01%	1011
2014 Q4	–	Sell	-25,364	Closed	-$243K	–	1696
2014 Q3	$243K	Hold	25,364	–	–	﹤0.01%	1056
2014 Q2	$293K	Hold	25,364	–	–	﹤0.01%	879
2014 Q1	$254K	Sell	25,364 -100	-0.4%	-$1.44K	﹤0.01%	905
2013 Q4	$331K	Buy	25,464 +100	+0.4%	+$1.38K	﹤0.01%	804
2013 Q3	$378K	Hold	25,364	–	–	﹤0.01%	973
2013 Q2	$237K	Buy	+25,364	New	+$172K	﹤0.01%	1122

Other funds holding RPTP

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Highbridge Capital Management's RPTP Position: Q1 2016 in Review

Highbridge Capital Management sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q1 2016, closing a stake of 91,286 shares — an estimated $475K sold.

Highbridge Capital Management first reported a position in RPTP in Q2 2013 and held it in 7 quarters. The position peaked at $475K in Q4 2015. 97 funds tracked by Wall St. Rank hold RPTP as of Q1 2016.

Highbridge Capital Management reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q1 2016 after selling out during the quarter.
Highbridge Capital Management sold 91,286 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q1 2016, an estimated $475K.
Highbridge Capital Management first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2013 and held it in 7 quarters.
Highbridge Capital Management's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $475K in Q4 2015.
97 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q1 2016.

Based on Highbridge Capital Management's 13F filing for Q1 2016, filed 16 May 2016.